Systematic literature review: xerostomia in advanced cancer patients

Supportive Care in Cancer

Volumn 23, Issue 3, 2015, Pages 881-888

  Hanchanale, Sarika ^a   Adkinson, Lucy ^a   Daniel, Sunitha ^a   Fleming, Michelle ^a   Oxberry, Stephen G ^b  

^a Yorkshire Deanery   (United Kingdom)

^b Kirkwood Hospice   (United Kingdom)

Author keywords

Advanced cancer; Artificial saliva; Pilocarpine; Xerostomia

Indexed keywords

PILOCARPINE; PLACEBO; SALIVA SUBSTITUTE; CHEWING GUM;

ACUPUNCTURE; ADVANCED CANCER; CANCER PATIENT; CHEWING GUM; COMPARATIVE EFFECTIVENESS; DRUG EFFICACY; HOME CARE; HUMAN; MOUTH HYGIENE; PHARMACEUTICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; XEROSTOMIA; ADULT; COMPLICATION; DISEASE COURSE; NEOPLASMS; PATHOLOGY; PROSPECTIVE STUDY; QUALITY OF LIFE;

ACUPUNCTURE THERAPY; ADULT; CHEWING GUM; DISEASE PROGRESSION; HUMANS; NEOPLASMS; PILOCARPINE; PROSPECTIVE STUDIES; QUALITY OF LIFE; SALIVA, ARTIFICIAL; XEROSTOMIA;

EID: 84922179901     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-014-2477-8     Document Type: Review

References (32)

1. von Bultzingslowen I, Sollecito TP, Fox PC, Daniels T, Jonsson R, Lockhart PB, Wray D, Brennan MT, Carrozzo M, Gandera B, Fujibayashi T, Navazesh M, Rhodus NL, Schiodt M (2007) Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surg, Oral Med, Oral Pathol, Oral Radiology Endod 103(S57):e51–15. doi:10.1016/j.tripleo.2006.11.010
2. Atkinson JC, Grisius M, Massey W (2005) Salivary hypofunction and xerostomia: diagnosis and treatment. Dent Clin N Am 49(2):309–326. doi:10.1016/j.cden.2004.10.002
3. Porter SR, Scully C, Hegarty AM (2004) An update of the etiology and management of xerostomia. Oral Surg, Oral Med, Oral Pathol, Oral Radiol Endod 97(1):28–46. doi:10.1016/S1079210403005572
4. Jobbins J, Bagg J, Finlay IG, Addy M, Newcombe RG (1992) Oral and dental disease in terminally ill cancer patients. BMJ 304(6842):1612
5. Shragge JE, Wismer WV, Olson KL, Baracos VE (2006) The management of anorexia by patients with advanced cancer: a critical review of the literature. Palliat Med 20(6):623–629. doi:10.1177/0269216306070322
6. Twycross R, Wilcock A, Toller C (2009) Alimentary symptoms. In: Twycross R, Wilcock A, Toller C (eds) Symptom management in advanced cancer, 4th edition. 4th edn. Palliativedrugs.com Ltd, Oxford, pp 62–65
7. Rydholm M, Strang P (2002) Physical and psychosocial impact of xerostomia in palliative cancer care: a qualitative interview study. Int J Palliat Nurs 8(7):318–323
8. Davies A, Bagg J, Laverty D, Sweeney P, Filbet M, Newbold K, De Andres J, Mercadante S (2010) Salivary gland dysfunction (‘dry mouth’) in patients with cancer: a consensus statement. Eur J Cancer Care 19(2):172–177. doi:10.1111/j.1365-2354.2009.01081.x
9. Twycross R, Wilcock A (2012) Ear nose and oropharynx. In: Twycross R, Wilcock A (eds) PCF4- palliative care formulary. Radcliffe Press, Oxford, pp 569–573
10. Davies AN, Broadley K, Beighton D (2002) Salivary gland hypofunction in patients with advanced cancer. Oral Oncol 38(7):680–685
11. Simcock R, Shields P (2011) Management of radiation induced xerostomia in the UK. Clin Oncol 23(1):S53
12. Adkinson L, Hussain J, Daniel S, Oxberry S (2014) Oral health is an important issue in end-of-life care, December 2012. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 22(2):293–294. doi:10.1007/s00520-013-1992-3
13. Wilberg P, Hjermstad MJ, Ottesen S, Herlofson BB (2012) Oral health is an important issue in end-of-life cancer care. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 20(12):3115–3122. doi:10.1007/s00520-012-1441-8
14. De Conno F, Ripamonti C, Sbanotto A, Ventafridda V (1989) Oral complications in patients with advanced cancer. J Palliat Care 5(1):7–15
15. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1–12
16. STROBE Statement: http://www.strobe-statement.org/index.php?id=available-checklists. http://www.strobe-statement.org/index.php?id=available-checklists. Accessed 8th Aug 2014
17. Davies AN (2000) A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer. Palliat Med 14(3):197–203
18. Davies AN, Daniels C, Pugh R, Sharma K (1998) A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer. Palliat Med 12(2):105–111
19. Mercadante S, Calderone L, Villari P, Serretta R, Sapio M, Casuccio A, Fulfaro F (2000) The use of pilocarpine in opioid-induced xerostomia. Palliat Med 14(6):529–531
20. Rydholm M, Strang P (1999) Acupuncture for patients in hospital-based home care suffering from xerostomia. J Palliat Care 15(4):20–23
21. Meidell L, Holritz Rasmussen B (2009) Acupuncture as an optional treatment for hospice patients with xerostomia: an intervention study. Int J Palliat Nurs 15(1):12–20
22. Sweeney MP, Bagg J, Baxter WP, Aitchison TC (1997) Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients. Palliat Med 11(3):225–232
23. Braga MA, Tarzia O, Bergamaschi CC, Santos FA, Andrade ED, Groppo FC (2009) Comparison of the effects of pilocarpine and cevimeline on salivary flow. Int J Dent Hyg 7(2):126–130. doi:10.1111/j.1601-5037.2008.00326.x
24. Loostrom H, Akerman S, Ericson D, Tobin G, Gotrick B (2011) Tramadol-induced oral dryness and pilocarpine treatment: effects on total protein and IgA. Arch Oral Biol 56(4):395–400. doi:10.1016/j.archoralbio.2010.10.019
25. Towler P, Molassiotis A, Brearley SG (2013) What is the evidence for the use of acupuncture as an intervention for symptom management in cancer supportive and palliative care: an integrative overview of reviews. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 21(10):2913–2923. doi:10.1007/s00520-013-1882-8
26. Kim JO, Kim NC (2014) Effects of 4% hypertonic saline solution mouthwash on oral health of elders in long term care facilities. J Korean Acad Nurs 44(1):13–20. doi:10.4040/jkan.2014.44.1.13
27. Senn HJ (1997) Orphan topics in supportive care: how about xerostomia? Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 5(4):261–262
28. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napenas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bultzingslowen I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT, Salivary Gland Hypofunction/Xerostomia S, Oral Care Study G, Multinational Association of Supportive Care in Cancer /International Society of Oral O (2010) A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 18(8):1061–1079. doi:10.1007/s00520-010-0837-6
29. Furness S, Worthington HV, Bryan G, Birchenough S, McMillan R (2011) Interventions for the management of dry mouth: topical therapies. The Cochrane database of systematic reviews (12):CD008934. doi:10.1002/14651858.CD008934.pub2
30. Sullivan CA, Haddad RI, Tishler RB, Mahadevan A, Krane JF (2005) Chemoradiation-induced cell loss in human submandibular glands. Laryngoscope 115(6):958–964. doi:10.1097/01.MLG.0000163340.90211.87
31. Chambers MS, Artopoulou L, Garden AS (2007) Xerosomia. In: Myers EN, Ferris RL (eds) Salivary gland disorders. Springer, Berlin, pp 185–199
32. Chambers MS, Garden AS, Kies MS, Martin JW (2004) Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck 26(9):796–807. doi:10.1002/hed.20045